Advertisement

Competitive Intelligence Summary

  • Raymond A. Huml
Chapter
Part of the SpringerBriefs in Pharmaceutical Science & Drug Development book series (BRIEFSPSDD)

Abstract

If trends continue, it is highly likely that regulatory professionals will become involved in one or more aspects of a due diligence process and be tasked with the identification of competitive intelligence. They will play a major role in evaluating risk-based transactions and competitive assessments which, for regulatory affairs professionals, consist of a determination of the actual product profile, likelihood of regulatory approval (with timing), and a determination of how that product profile (via the actual product labeling) stacks up against the competition.

Keywords

Competitive Intelligence Regulatory Professional Investment Committee Diligence Contribution Competitive Assessment 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Springer Science+Business Media New York 2012

Authors and Affiliations

  • Raymond A. Huml
    • 1
  1. 1.Quintiles Transnational CorporationDurhamUSA

Personalised recommendations